Aprea Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Aprea Therapeutics (APRE) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Aprea Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aprea Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aprea Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $233k | 158k | 1.48 |
| 2025-06-30 | $296k | 174k | 1.70 |
| 2025-03-31 | $355k | 174k | 2.04 |
| 2024-12-31 | $570k | 174k | 3.28 |
| 2024-09-30 | $478k | 174k | 2.75 |
| 2024-06-30 | $472k | 116k | 4.07 |
| 2024-03-31 | $776k | 116k | 6.69 |
| 2023-12-31 | $163k | 35k | 4.70 |
| 2023-09-30 | $114k | 27k | 4.17 |
| 2023-06-30 | $49k | 16k | 3.15 |
| 2023-03-31 | $69k | 16k | 4.44 |